<DOC>
	<DOCNO>NCT02644980</DOCNO>
	<brief_summary>For patient require heart valve replacement surgery , heart function injure different degree.Thus , minimize impact anesthesia drug cardiovascular system important clinical meaning . Etomidate slight effect cardiovascular system , often use induction anesthesia , however target control infusion etomidate maintenance anesthesia less use . So , trial design observe application value TCI etomidate thoracoscopic mitral valve replacement surgery .</brief_summary>
	<brief_title>Target Controlled Infusion Etomidate Propofol Anesthesia Thoracoscopic Mitral Valve Replacement Surgery</brief_title>
	<detailed_description />
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Etomidate</mesh_term>
	<criteria>1 . Age 18~75 year old 2 . Selective cardiopulmonary bypass thoracoscopic mitral vale replacement surgery 3 . Received heart surgery first time 4 . New York Heart Association ( NYHA ) II~III 5 . Written inform consent 1 . Emergency surgery 2 . Anticipated survival time &lt; 1 yr 3 . Serious heart , brain , liver , kidney , lung , endocrine disease serious infection 4 . Prolonged use hormone history adrenal suppression disease 5 . Severe mediastinal fiber thicken fibrous adhesion 6 . Allergy experimental drug contraindication 7 . Occurred expect occur difficulty airway 8 . Sure suspect narcotic analgesic abuse 9 . History neuromuscular disease 10 . Mental instability metal disease 11 . Pregnancy brestfeeding 12 . Participated clinical trial past 30 day 13 . Malignant hyperthermia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Target Controlled Infusion</keyword>
</DOC>